Physician profile
Katie E Stuckey
NPI 1053935023
$1,109.25
in general payments reported to CMS, 2019-2025
11 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.17 · 2022: $26.36 · 2023: $277 · 2024: $464 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.13 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $594.41 | 2023-2025 | Acthar |
| Rxsight INC | $197.20 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Alcon Vision LLC | $102.93 | 2021-2025 | Precision 1, Hydrus Microstent, Total30 |
| Bausch & Lomb Americas INC. | $71.30 | 2025 | Xiidra, Miebo |
| Astellas Pharma US INC | $28.94 | 2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $26.36 | 2022 | |
| Oyster Point Pharma, INC. | $23.58 | 2023 | Tyrvaya |
| Coopervision INC. | $18.26 | 2024 | Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.10 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $15.49 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Stuckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.